268 related articles for article (PubMed ID: 16135812)
1. Pathway- and expression level-dependent effects of oncogenic N-Ras: p27(Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling.
Kfir S; Ehrlich M; Goldshmid A; Liu X; Kloog Y; Henis YI
Mol Cell Biol; 2005 Sep; 25(18):8239-50. PubMed ID: 16135812
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
Schepers H; Wierenga AT; Eggen BJ; Vellenga E
Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
[TBL] [Abstract][Full Text] [Related]
3. Disruption of TGF-beta growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization.
Liu X; Sun Y; Ehrlich M; Lu T; Kloog Y; Weinberg RA; Lodish HF; Henis YI
Oncogene; 2000 Nov; 19(51):5926-35. PubMed ID: 11127824
[TBL] [Abstract][Full Text] [Related]
4. Dual effects of Ral-activated pathways on p27 localization and TGF-β signaling.
Tazat K; Harsat M; Goldshmid-Shagal A; Ehrlich M; Henis YI
Mol Biol Cell; 2013 Jun; 24(11):1812-24. PubMed ID: 23576547
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta induces Cdk2 relocalization to the cytoplasm coincident with dephosphorylation of retinoblastoma tumor suppressor protein.
Brown KA; Roberts RL; Arteaga CL; Law BK
Breast Cancer Res; 2004; 6(2):R130-9. PubMed ID: 14979923
[TBL] [Abstract][Full Text] [Related]
7. Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer.
Park BJ; Park JI; Byun DS; Park JH; Chi SG
Cancer Res; 2000 Jun; 60(11):3031-8. PubMed ID: 10850453
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic ras represses transforming growth factor-beta /Smad signaling by degrading tumor suppressor Smad4.
Saha D; Datta PK; Beauchamp RD
J Biol Chem; 2001 Aug; 276(31):29531-7. PubMed ID: 11371552
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.
Hayashida T; Decaestecker M; Schnaper HW
FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291
[TBL] [Abstract][Full Text] [Related]
11. A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.
Kretzschmar M; Doody J; Timokhina I; Massagué J
Genes Dev; 1999 Apr; 13(7):804-16. PubMed ID: 10197981
[TBL] [Abstract][Full Text] [Related]
12. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway.
Chen RH; Su YH; Chuang RL; Chang TY
Oncogene; 1998 Oct; 17(15):1959-68. PubMed ID: 9788439
[TBL] [Abstract][Full Text] [Related]
13. Beta-hydroxybutyrate-induced growth inhibition and collagen production in HK-2 cells are dependent on TGF-beta and Smad3.
Guh JY; Chuang TD; Chen HC; Hung WC; Lai YH; Shin SJ; Chuang LY
Kidney Int; 2003 Dec; 64(6):2041-51. PubMed ID: 14633126
[TBL] [Abstract][Full Text] [Related]
14. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
15. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
16. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis.
Conery AR; Cao Y; Thompson EA; Townsend CM; Ko TC; Luo K
Nat Cell Biol; 2004 Apr; 6(4):366-72. PubMed ID: 15104092
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.
Hu X; Zhang X; Zhong Q; Fisher AB; Bryington M; Zuckerman KS
Oncogene; 2001 Oct; 20(47):6840-50. PubMed ID: 11687963
[TBL] [Abstract][Full Text] [Related]
18. Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms.
Panopoulou E; Murphy C; Rasmussen H; Bagli E; Rofstad EK; Fotsis T
Cancer Res; 2005 Mar; 65(5):1877-86. PubMed ID: 15753386
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA.
Zhao BM; Hoffmann FM
Mol Biol Cell; 2006 Sep; 17(9):3819-31. PubMed ID: 16775010
[TBL] [Abstract][Full Text] [Related]
20. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest.
Liang J; Zubovitz J; Petrocelli T; Kotchetkov R; Connor MK; Han K; Lee JH; Ciarallo S; Catzavelos C; Beniston R; Franssen E; Slingerland JM
Nat Med; 2002 Oct; 8(10):1153-60. PubMed ID: 12244302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
